Clinical Trial: Phase II clinical study of irinotecan liposome combined with furoquininib in the third-line and beyond patients with advanced colorectal cancer (China)

China, Oct. 27 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Phase II clinical study of irinotecan liposome combined with furoquininib in the third-line and beyond patients with advanced colorectal cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135181

Registration Time: 2026/10/26

Type: Interventional study

Primary Sponsor: Guangxi Medical University Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=332734

Published by HT Digital Content Services with permission from Health Daily Digest....